Supports GLP-1 Programs by Preventing Fatigue & Muscle Loss GLP-1 patients commonly experience: Lower energy Reduced protein intake Muscle loss risk Slower workout performance NAD+ injections help solve this by: Increasing mitochondrial energy Improving workout intensity Supporting muscle recovery Enhancing fat burning without stimulants This keeps patients energized, strong, and motivated throughout their GLP-1 treatment
Its expression appears lower in patients with NASH [110]
That makes it much easier to stay in a calorie deficit without feeling miserable
doi: 10.1016/j.cellsig.2011.08.010 58 FunderburkSFShatkinaLMinkSWeisQWeg-RemersSCatoACB
The main difference is that the same side effects may be listed as common for Mounjaro but very common for Wegovy, and so on
I dont think so, but yeah, I do think that the elephant in the room here is how do you, how do you sustain this in, in a way that people dont just fall off a cliff once they come off it